BIOSIMILARS CONGRESS INDIA 2018

The impact of two key events- a phase of unprecedented patent expiration on many of the blockbuster biologics and financial crisis demanding significant and sustained cost reductions in the healthcare market is constantly changing the global Biosimilars landscape. The biosimilar is a lucrative sector owing to recent regulatory approvals and increasing opportunities. Biosimilars are at different stages of evolution across the globe.  Developing a biosimilars demands huge investment, technical capabilities and clinical trial expertise. In order to unlock the biosimilars potential, the industry will entail focused strategies along the whole value chain, from optimizing the clinical development program to commercialization.

Others Details

In this limelight, CPhI Conferences is pleased to announce the 3rd Annual Biosimilars Congress India 2018 conference on 23rd - 24th August 2018 in Hyderabad. This conference will congregate top industry stalwarts to discuss key challenges and best practices from development to launch of Biosimilars.